MK-0752(902240-86-2)
- Name: MK-0752
- Synonyms:
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:902240-86-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.902240-86-2 MK-0752
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.902240-86-2 MK-0752
Assay:99% Appearance:White fine powder Package:according to the clients requirement Storage:Store in dry dark and ventilated place Transportation:Transportation by express, air, sea; port mainly to Qingdao / Tianjin / Shanghai, or according to customer needs to send different ports and aviation. Application:It is an important raw material.
Min. Order:1Kilogram
Supplier:Shandong Hanjiang Chemical Co., Ltd. [
China (Mainland)] CAS No.902240-86-2 MK-0752
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.902240-86-2 902240-86-2 CAS NO.902240-86-2
Assay:99% Appearance:White powder or granule Package:25kg drum/bag Storage:Keep in dry and cool place Transportation:by Sea, air and express Application:Used as a calcium booster in the food industry
Min. Order:1Metric Ton
Supplier:KAISA GROUP INC [
United States] CAS No.902240-86-2 MK-0752
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:MK-0752
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.902240-86-2 902240-86-2
Assay:99% Application:api
Min. Order:0
Supplier:Jilin Artel New Materials Co., LTD [
China (Mainland)]
Other Product
- 847559-80-2/NVP-BEP800
- 1134156-31-2/5'-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-adenosine
- 211735-76-1/FARAMPATOR
- 175340-20-2/S 18986
- 376594-67-1/LY 450108
- 375345-95-2/MibaMpator
- 1045805-41-1/2-Propanesulfonamide, N-[(2S)-2,3-dihydro-5-(6-methyl-3-pyridinyl)-1H-inden-2-yl]-
- 1238673-32-9/UNC0321
- 1197196-48-7/UNC 0224
- 1123741-50-3/1,3-Benzenedicarbonitrile, 5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]-
- 802916-41-2/[2,3'-Bipyridine]-3-carboxamide, 6-[[(1S)-1-(hydroxymethyl)-2-phenylethyl]amino]-2',6'-dimethoxy-N-(2-phenoxyethyl)-
- 682336-41-0/Spiro[piperidine-4,5'(6'H)-[1H][1,2,4]triazolo[1,2-a]pyridazine]-8'-carboxamide, N-[(1S)-1-[[[(1S)-(aminocarbonyl)-3-phenylpropyl]amino]carbonyl]-3-phenylpropyl]-2'-(1,3-benzodioxol-5-ylmethyl)tetrahydro-1',3'-dioxo-, (8'S)-
- 1127440-16-7/Benzenepropanamide, N-[(1R)-2-[4-[[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]amino]-1-piperidinyl]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-
- 223132-38-5/CS 7017
- 174671-46-6/5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL
- 872044-70-7/AN-0128
- 906673-24-3/5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
- 747412-64-2/AUY 922
- 902240-76-0/Cyclohexanepropanoic acid, 3-[(4-chlorophenyl)sulfonyl]-3-(2,5-difluorophenyl)-, (1R,3R)-rel-
- 902240-86-2/MK-0752
- 850140-72-6/Afatinib
- 1028486-01-2/MLN-8237
- 1094042-01-9/2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride
- 1056636-07-7/CYT387,MsOH salt
- 1056636-06-6/CYT387 2H2SO4 salt
- 1056634-68-4/Momelotinib
- 847157-12-4/Hexanamide, 2-[[[(4S)-17-[methyl(methylsulfonyl)amino]-2-oxo-3-azatricyclo[13.3.1.16,10]eicosa-1(19),6,8,10(20),15,17-hexaen-4-yl]methyl]amino]-N-(2-methylpropyl)-, (2S)-
- 1093486-14-6/rac D-205 Dye
- 918333-06-9/Benzamide, 3,5-dichloro-N-[[(3S,4R)-1-(3,3-dimethylbutyl)-3-fluoro-4-piperidinyl]methyl]-
- 357606-66-7/(R)-ONO-AE2-227